SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Walgreens Boots Alliance, Inc. (WBA) , forward earnings yield 13.07%. PEG 1.01.
Criteria proven by this page:
- VALUE (10/100, Fail) — analyst consensus target implies downside from the current price ($9.00, 24.9%).
- Forward P/E 7.7
- PEG Ratio 1.01 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Analyst consensus target $9.00 (-24.9% downside) — analysts see meaningful downside risk at the current price level.
Overall SharesGrow Score: 24/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — WBA
Valuation Multiples
P/E (TTM)0.0
Forward P/E7.7
PEG Ratio1.01
Forward PEG1.01
P/B Ratio0.00
P/S Ratio0.07
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-10.01
Forward EPS (Est.)$1.57
Book Value / Share$0.00
Revenue / Share$171.08
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Forward Earnings Yield13.07%
Dividend Yield0.00%
Analyst Target$9.00 (-24.9%)
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$4.00 |
$103.44B |
$4.22B |
4.1% |
| 2016 |
$3.82 |
$117.35B |
$4.17B |
3.6% |
| 2017 |
$3.78 |
$118.21B |
$4.08B |
3.4% |
| 2018 |
$5.05 |
$131.54B |
$5.02B |
3.8% |
| 2019 |
$4.13 |
$120.07B |
$3.98B |
3.3% |
| 2020 |
$0.20 |
$121.98B |
$456M |
0.4% |
| 2021 |
$2.30 |
$132.51B |
$2.54B |
1.9% |
| 2022 |
$5.01 |
$132.7B |
$4.34B |
3.3% |
| 2023 |
$-3.57 |
$139.08B |
$-3.08B |
-2.2% |
| 2024 |
$-10.01 |
$147.66B |
$-8.64B |
-5.8% |
